Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Capecitabine-Induced Hand and Foot Syndrome
NCT05327751Phase 3Unknown
- Sponsor
- Tanta University
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in hand-foot syndrome (HFS), sponsored by Tanta University. Status: unknown.
02
Drugs
celecoxib oral solution
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT05327751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327751.